Turning RNA Research into Medicines

RNA research has long claimed to be a disruptive treatment opportunity, utilizing carefully designed molecules to prompt the body to make its own medicine. With early demonstrations of success in COVID-19 vaccines development touting 90%+ efficacy, there is new excitement in this space, attracting new investments and partnerships. However, the RNA ride has been a rocky one with wins and losses, with some companies investing up to $100m per year in research. Hear from drug developers and scientists as they share their stories and what's to come to realize the long-term vision.